Laboratory Interpretation and Treatment Recommendation
This patient requires immediate treatment with penicillin or amoxicillin for 10 days for the Group A streptococcal pharyngitis, PLUS a separate antibiotic regimen for the cellulitis—specifically a penicillinase-resistant penicillin (nafcillin or cefazolin IV) or oral dicloxacillin/cephalexin if the cellulitis is mild enough for outpatient management.
Laboratory Interpretation
The labs reveal a concerning picture:
- Severe leukocytosis (WBC 16.96) with marked neutrophilia (85.8%, absolute 14.58) and profound lymphopenia (3.5%, absolute 0.59)—this pattern indicates acute bacterial infection with significant systemic inflammatory response
- Mild anemia (RBC 3.89) with elevated RDW-SD suggesting possible chronic inflammation or nutritional deficiency
- Low albumin/globulin ratio (1.0) indicates acute phase response
- Normal lactic acid is reassuring—no evidence of septic shock currently
This laboratory picture combined with positive Group A strep and cellulitis indicates two distinct but concurrent Group A streptococcal infections requiring comprehensive treatment.
Treatment Algorithm
For Group A Streptococcal Pharyngitis:
Penicillin or amoxicillin remains the drug of choice based on narrow spectrum, proven efficacy, safety profile, and low cost 1. The IDSA guideline provides strong, high-quality evidence for this recommendation.
Specific regimens:
- Penicillin V oral for 10 days, OR
- Amoxicillin 50 mg/kg once daily (maximum 1000 mg) for 10 days—this offers once-daily dosing advantage for adherence 1
If penicillin-allergic:
- First-generation cephalosporin for 10 days (if not anaphylactic allergy)
- Clindamycin or clarithromycin for 10 days
- Avoid azithromycin—recent 2026 network meta-analysis demonstrates inferior early bacterial eradication (OR 0.53), late bacterial eradication (OR 0.38), and increased adverse events compared to penicillin 2
For Cellulitis:
The cellulitis requires separate consideration because while Group A streptococcus is the most common cause, treatment must account for potential S. aureus involvement and severity 3.
Severity assessment determines route:
For severe cellulitis (given the marked leukocytosis and systemic response):
- Nafcillin IV or cefazolin IV (first-generation cephalosporin) 3
- These cover both streptococci and S. aureus
- Duration: 5 days is as effective as 10 days for uncomplicated cellulitis 3
For mild cellulitis (if outpatient management appropriate):
- Dicloxacillin or cephalexin oral
- Clindamycin if penicillin-allergic 3
Critical Management Points
Elevation of affected area is essential but often neglected—this accelerates resolution by promoting gravity drainage 3.
Examine interdigital toe spaces if lower extremity cellulitis—treat any tinea pedis or fissuring as these serve as streptococcal reservoirs 3.
Monitor for worsening inflammation in first 24-48 hours after antibiotic initiation—this paradoxical worsening occurs from bacterial lysis releasing inflammatory enzymes. One RCT showed 8-day tapering prednisolone (starting 30 mg) shortened healing time by 1 day in uncomplicated erysipelas 3. Consider corticosteroids as adjunct in selected adult patients if inflammation worsens.
Expect clinical response within 24-48 hours of appropriate therapy 1. If no improvement by 5 days or worsening symptoms, reevaluate for deeper infection, abscess, or resistant organism 4.
Common Pitfalls to Avoid
Do not use azithromycin—significant regional resistance exists in the US for GAS pharyngitis, and the 2026 network meta-analysis confirms inferior outcomes 1, 2.
Do not treat pharyngitis and cellulitis as a single entity—while both are GAS infections, cellulitis requires broader coverage for potential S. aureus and different duration (5 vs 10 days).
Do not forget the 10-day duration for pharyngitis—shorter courses have inferior bacterial eradication rates except for specific agents like azithromycin (which should be avoided anyway) 1.
Do not overlook predisposing factors—address tinea pedis, venous insufficiency, or other entry points to prevent recurrence 3.